Roy Lester Freeman - Net Worth and Insider Trading

Roy Lester Freeman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roy Lester Freeman owns 1 companies in total, including Inhibikase Therapeutics Inc (IKT) .

Click here to see the complete history of Roy Lester Freeman’s form 4 insider trades.

Insider Ownership Summary of Roy Lester Freeman

Ticker	Comapny	Transaction Date	Type of Owner
IKT	Inhibikase Therapeutics Inc	2023-06-30	director

Roy Lester Freeman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Roy Lester Freeman Ownership Network

Ownership Network List of Roy Lester Freeman

No Data

Ownership Network Relation of Roy Lester Freeman

Roy Lester Freeman Owned Company Details

What does Inhibikase Therapeutics Inc do?

Who are the key executives at Inhibikase Therapeutics Inc?

Roy Lester Freeman is the director of Inhibikase Therapeutics Inc. Other key executives at Inhibikase Therapeutics Inc include director & 10 percent owner & President and CEO Milton H. Werner , Cheif Financial Officer Joseph Frattaroli , and 10 percent owner Daniel Kalman .

Inhibikase Therapeutics Inc (IKT) Insider Trades Summary

Over the past 18 months, Roy Lester Freeman made no insider transaction in Inhibikase Therapeutics Inc (IKT). Other recent insider transactions involving Inhibikase Therapeutics Inc (IKT) include a net purchase of 1,460,000 shares made by , a net purchase of 365,000 shares made by Amit Munshi , and a net purchase of 145,000 shares made by Arvind Kush .

In summary, during the past 3 months, insiders sold 0 shares of Inhibikase Therapeutics Inc (IKT) in total and bought 1,970,000 shares, with a net purchase of 1,970,000 shares. During the past 18 months, 0 shares of Inhibikase Therapeutics Inc (IKT) were sold and 1,970,000 shares were bought by its insiders, resulting in a net purchase of 1,970,000 shares.

Inhibikase Therapeutics Inc (IKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inhibikase Therapeutics Inc Insider Transactions

No Available Data

Roy Lester Freeman Mailing Address

Above is the net worth, insider trading, and ownership report for Roy Lester Freeman. You might contact Roy Lester Freeman via mailing address: 256 Summit Ave, Brookline Ma 02446.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.